UPC Analytics
ENDE
Overview · Filed: Jun 18, 2025

UPC_CFI_552/2025

USE OF SUBSTITUTED AMINOPROPIONATE COMPOUNDS IN TREATMENT OF SARS-COV-2 INFECTION

RevocationMain Revocation ActionMilan CDRevocationInterim Phase
Parties

Claimants

  • Gilead Sciences, Inc.

Respondents

  • Academy of Military Medical Sciences
Judges
  • Andrea Postiglione
  • Marije Knijff
  • Xavier Dorland-Galliot
Patents
  • EP3854403
CPC codes: A61P31/14, C07F9/6561, A61K31/685, A61P11/00, A61K31/675

Technology area: Pharmaceuticals · Small Molecule

Sector: Organic Chemistry

Outcome
Filed: Jun 18, 2025
First decided:
Language: English
Open on UPC Registry